Driving Laws and Prescribed Cannabis: Western Australia
What WA law actually says about drug driving
Western Australia's drug-driving framework sits in the Road Traffic (Administration) Act 2008 (WA) and the associated Road Traffic (Administration) Regulations 2014 (WA). The offence that catches prescribed cannabis patients is a presence offence, not an impairment offence.
That distinction is everything. An impairment offence requires police to demonstrate that a drug affected your driving. A presence offence requires only that a prescribed drug be detected in your oral fluid or blood. The legal standard is binary: detected or not detected. Your prescription does not change the test, and it does not provide a defence.
The drug tested for under roadside screening is tetrahydrocannabinol (THC) , the principal psychoactive cannabinoid in cannabis. Roadside oral fluid devices screen for THC specifically. Cannabidiol (CBD)-only products that contain no detectable THC would not trigger a positive oral fluid result on that basis alone, though any product containing even trace levels of THC carries real detection risk depending on the individual's metabolism and the sensitivity of the device used.
The oral fluid screening process
A WA police officer can require any driver to undergo a preliminary oral fluid test under the Road Traffic (Administration) Act 2008, s.66. There is no requirement for reasonable suspicion , it is a random-testing power, the same as the breath test framework.
If the preliminary test indicates the presence of THC, the driver is taken for a confirmatory oral fluid analysis. A positive confirmation leads to an infringement notice or charge. If a blood sample is required (for example following a crash), the blood analysis will detect and quantify cannabinoids including THC and its primary metabolite THC-COOH, the latter of which can persist in blood well beyond any window of likely impairment; sometimes days after last use, depending on frequency and individual pharmacokinetics.
The WA Police Force's testing protocols are published via the Road Safety Commission. The Road Safety Commission of WA is the state authority whose materials I'd recommend reading directly; the link is in the sources below.
Prescribed cannabis does not create an exemption
This is where patients sometimes get caught out, and honestly it's a point that deserves to be said plainly rather than buried in a paragraph of caveats.
In WA, holding a valid prescription for a cannabis product, whether accessed via the Special Access Scheme, through an Authorised Prescriber, or otherwise, does not exempt a driver from the presence offence. The Road Traffic (Administration) Act 2008 contains no medical exemption for THC detection equivalent to, say, the exemptions that exist in some other jurisdictions for certain prescribed drugs.
This stands in contrast to how other Schedule 8 medicines are treated. A driver on prescribed opioids, benzodiazepines, or other controlled drugs faces an impairment-based assessment rather than a pure presence test. THC is treated differently because it is specifically listed as a target substance under the oral fluid testing regime.
I'll admit I find this distinction philosophically interesting from a policy perspective; though that's a separate argument. The legal reality for WA drivers is what it is.
Detection windows: why this is harder than it looks
THC detection windows in oral fluid are variable. For infrequent users, oral fluid may clear within hours of last use. For regular users, or those using higher-THC preparations, detection can extend considerably longer. Blood THC-COOH detection can extend to days or weeks in chronic users.
The first-pass metabolism of orally administered cannabis (oil, capsules, edibles) differs meaningfully from inhaled routes, which affects both the pharmacokinetic profile and, in principle, detection windows, though the research on exactly how this translates to oral fluid concentrations at roadside testing levels is still evolving. A 2020 review in Forensic Science International (Milman et al.) documented substantial inter-individual variability in oral fluid THC concentrations following controlled cannabis administration, which underlines why no individual should assume they know their own clearance time with confidence.
The short version is: there is no reliably safe "wait this many hours" rule for THC and WA's oral fluid detection threshold. Anyone prescribed a THC-containing product needs to factor this into driving decisions in consultation with their prescribing clinician.
Federal scheduling and WA: how the two layers interact
Prescribed medicinal cannabis products in Australia are regulated federally via the TGA. Products reach patients through the Special Access Scheme, Authorised Prescriber pathway, or via a product on the ARTG. THC-containing products sit under Schedule 8 of the Poisons Standard; CBD products above 2% CBD sit under Schedule 4.
Federal scheduling governs supply, prescription, and possession (within the limits of the prescription). It does not govern road traffic law, which is entirely a state matter. The TGA approval of a product says nothing about whether a patient can lawfully drive after using it. These are two completely separate legal frameworks and confusing them is an easy mistake to make.
When I was working through the Poisons Standard one afternoon last winter, Trevor (the sourdough starter, not a colleague) bubbling away on the bench beside me, proving that slow fermentation and regulatory reading pair well; I kept noticing how often federal scheduling documents are cited in state drug-driving discussions as though one informs the other. They largely don't, for driving purposes. The state road traffic statute is the governing document in WA.
What patients should do
This article describes the legal framework; it is not legal advice, and it is definitely not clinical advice. If you are a patient prescribed a cannabis product and you have questions about driving, the right steps are:
- Speak directly with your prescribing clinician about the specific product, its THC content, and their clinical view on driving.
- Read the Road Safety Commission of WA's published guidance on drug driving.
- If you need legal advice about a specific situation, consult a WA traffic lawyer.
Prescribers in WA have an obligation to counsel patients on driving. If yours hasn't raised it, it is entirely reasonable to ask.
Other states differ, and laws change
Each Australian state and territory runs its own road traffic regime. Victoria, New South Wales, Queensland, South Australia, and the ACT all have different statutory language, different detection thresholds (where thresholds apply), and different levels of activity around reform. Some jurisdictions have been more active than others in examining whether a prescribing defence ought to exist.
The WA framework described above reflects the legislation and published guidance current at the time of writing. Road traffic laws are amended periodically, and the status of driving and prescribed cannabis is a live policy area nationally. Always verify the current position directly with the Road Safety Commission of WA or a qualified legal practitioner rather than relying solely on any third-party summary, including this one.
For background on the cannabinoids involved, particularly THC and how it interacts with receptors in the central nervous system; our glossary entries on the endocannabinoid system, CB1 receptor, and tetrahydrocannabinol cover the mechanistic picture without crossing into therapeutic claims.
Sources
- Drug Driving, Road Safety Commission of Western Australia
- Road Traffic (Administration) Act 2008, Parliament of Western Australia
- Accessing Medicinal Cannabis Products in Australia; Therapeutic Goods Administration
- Milman G et al., "Oral Fluid THC Concentrations Following Controlled Cannabis Administration", NCBI / Forensic Science International (2020)
, Marcus Hale, Regulatory researcher, TGA & access law
]]>Common questions
- Does a valid prescription for medicinal cannabis mean I can legally drive in WA?
- No. Western Australia's drug-driving laws create a 'presence offence' — meaning that if THC is detected in your oral fluid or blood, you can be charged regardless of whether you hold a valid prescription. There is no medical exemption for THC under the Road Traffic (Administration) Act 2008 (WA) equivalent to those that exist for some other prescribed medicines.
- What drug does WA roadside testing actually detect?
- Roadside oral fluid screening devices test specifically for THC (tetrahydrocannabinol). CBD-only products containing no detectable THC would not trigger a positive result on that basis, but any product with even trace levels of THC carries detection risk. Blood analysis following a crash can additionally detect THC-COOH, a metabolite that can persist in blood for days.
- How long does THC stay detectable in oral fluid?
- Detection windows vary significantly between individuals and depend on factors including frequency of use, the specific product, the route of administration, and individual metabolism. For infrequent users, oral fluid may clear within hours; for regular users, detection can extend considerably longer. There is no universally reliable 'safe waiting time' — this is a question to raise with your prescribing clinician.
- My doctor prescribed the cannabis — why can't I drive?
- Federal TGA scheduling (which governs whether a product can be prescribed and supplied) and state road traffic law are two entirely separate legal frameworks. The TGA approving a product for prescription use has no bearing on WA road traffic offences, which are governed solely by state legislation. Holding a Schedule 8 or Schedule 4 prescription does not provide a driving defence in WA.
- Where can I find the current official WA guidance on drug driving?
- The Road Safety Commission of Western Australia publishes guidance on drug driving at rsc.wa.gov.au. For the legislation itself, the Road Traffic (Administration) Act 2008 (WA) is publicly available through the WA State Law Publisher at legislation.wa.gov.au. Both are authoritative state sources and should be checked for any updates, as laws in this area can change.
Related reading
TGA Good Manufacturing Practice LicensingTGA GMP licensing sits at the heart of Australia's medicinal cannabis supply chain. Here's how the framework works, and why it matters for product quality.
State vs Federal Drug Regulation in AustraliaFederal scheduling sets the rules, but states enforce them differently. Here's how Australia's split drug regulation system actually works for cannabis access.
The Therapeutic Goods Administration (TGA) ExplainedThe Therapeutic Goods Administration shapes every legal cannabis pathway in Australia. See how scheduling, the ARTG, SAS and Authorised Prescriber work.
Medicinal Cannabis Access in Tasmania: A Regulatory OverviewTasmania sits inside the same federal medicinal cannabis framework as every other state — but the state layer adds its own wrinkle. Here's how access actually works.
The Prescriber’s Role in AccessThe prescriber's role in access to medicinal cannabis in Australia: who can prescribe, and how the SAS and Authorised Prescriber pathways differ.
Special Access Scheme Category ACategory A of Australia's Special Access Scheme explained — who it covers, how it works, and where it sits in the TGA's regulatory framework for unapproved medicines.
Ex policy analyst, now I spend my days reading the Poisons Standard so other people do not have to. I cover how access pathways and scheduling really work. Weekends are for long road rides, vintage survey maps, and a sourdough starter named Trevor.
Grad. Cert. Regulatory Affairs
More from Marcus Hale
Importing Medicines: The Personal Importation SchemeAustralia's Personal Importation Scheme lets travellers bring in small quantities of medicines — but the rules for cannabis and controlled drugs are stricter than most people realise.
Cannabis Law and Access in TurkeyTurkey's cannabis legal framework is stricter than many assume. Here's how cultivation, medical access, and enforcement actually work under Turkish law.
Cannabis Law and Access in UkraineUkraine legalised medical cannabis in 2022. Here's how the legal framework actually works — the schedules, the access rules, and what's still missing.
Cannabis Law and Access in NetherlandsThe Netherlands runs one of the world's most studied cannabis frameworks — but it is not legalisation. Here is how the gedoogbeleid model actually works.
CBD and Down-Scheduling in AustraliaHow Australia's 2021 CBD down-scheduling actually works, what changed in the Poisons Standard, and why access remains more complicated than headlines suggest.
Cannabis Law and Access in PeruPeru legalised medical cannabis in 2017, but the regulatory detail is genuinely complex. Here's how the framework actually works — and what it means for AU readers.